Home > Insider Trading > Filing (0001144204-12-065878)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
868278	Prophase Labs Inc.	PRPH	Pharmaceutical Preparations (2834)	232577138

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1459632	S Mark Leventhal	621 N. Shady Retreat Road Doylestown PA 18901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	Acquisiton	2012-11-28	47,300	$1.42	47,300	No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.
Common Stock, Par Value $0.0005	Acquisiton	2012-11-29	102,700	$1.60	150,000	No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.
No	4	P	Indirect	By Mark S & Donna R Leventhal Family Foundation Inc.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	290,195	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4193 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.599 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.